CheckEye is an AI-driven mass screening solution that aims to enable preventive healthcare for everyone around the world. The platform utilizes AI algorithms to conduct mass screenings for various health conditions, with 40+ diseases in the roadmap including Diabetic Retinopathy, Arterial Hypertension, eye diseases, Alzheimer, Parkinson, and more. Founded in 2022 and headquartered in Ukraine, the startup received non-equity assistance investment from WorldUpstart on 01 February 2024. By offering accessible and affordable screening services, CheckEye seeks to enable access and improve healthcare outcomes globally, particularly targeting chronic diseases and their potential impacts on the population. The startup operates in the Health Care and Medical Devices industries and is poised to make a significant impact on preventive healthcare through its innovative AI-driven approach.
No recent news or press coverage available for CheckEye.